Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna ClinicalTrials.gov registry by Year
ClinicalTrials.gov registry — Cumulative Moderna-sponsored studies (studies)
Moderna ClinicalTrials.gov registry: 135.00 studies in FY2025, up 10.7% from a year earlier. That is the highest of the 8 years on record here.
Where the FY2025 figure comes from
Source: ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Reported in ClinicalTrials.gov API v2 (ModernaTX, Inc.).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | ClinicalTrials.gov registry — Cumulative Moderna-sponsored studies (studies) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 135.00 | +10.7% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2024 | Dec 31, 2024 | 122.00 | +16.2% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2023 | Dec 31, 2023 | 105.00 | +40.0% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2022 | Dec 31, 2022 | 75.00 | +56.3% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2021 | Dec 31, 2021 | 48.00 | +100.0% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2020 | Dec 31, 2020 | 24.00 | +41.2% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2019 | Dec 31, 2019 | 17.00 | +54.5% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2018 | Dec 31, 2018 | 11.00 | – | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
Breakdown
What makes up clinicalTrials.gov registry
- Cumulative interventional clinical trials (trials)112.00 · FY2025
- Cumulative Phase 1 clinical trials (trials)33.00 · FY2025
- Cumulative Phase 2 clinical trials (trials)45.00 · FY2025
- Cumulative Phase 3 registrational clinical trials (trials)32.00 · FY2025
- Cumulative respiratory vaccine trials (COVID-19, RSV, Flu, Combo) (trials)53.00 · FY2025
- Cumulative oncology & individualized neoantigen therapy (mRNA-4157) trials (trials)18.00 · FY2025
- Cumulative latent virus, rare disease & other therapeutic trials (trials)41.00 · FY2025
- Cumulative participant enrollment across interventional clinical trials (participants)464,168.00 · FY2025
- Newly initiated Moderna clinical studies in period (studies)13.00 · FY2025
Cite this data
StockData. (2026). Moderna ClinicalTrials.gov registry, annual FY2018–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/ctgov-cum-all-studies
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.